ANK1 p.Val1755Val

Variant summary

Our verdict is Likely benign.
-2 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateB4_Strong

The NM_000037.4(ANK1):c.5265G>T (p.Val1755Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)

Consequence

ANK1
NM_000037.4 synonymous

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.27

Publications

0 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • hereditary spherocytosis type 1
    Inheritance: SD, AR, AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000037.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
B4Synonymous/intronic, no splicing impact
Synonymous/intronic variant with confirmed no splicing impact (B4 strong); Synonymous variant — splicing algorithms confirm no impact on splicing (B4 strong [-4])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ANK1 NM_000037.4
MANE Select
HGVSc / HGVSpc.5265G>Tp.Val1755Val
Exon rankExon 39 of 43
synonymous
Prot: NP_000028.3
ANK1 NM_001142446.2
HGVSc / HGVSpc.5388G>Tp.Val1796Val
Exon rankExon 40 of 43
synonymous
Prot: NP_001135918.1UniProt: P16157-21
ANK1 NM_020476.3
HGVSc / HGVSpc.5265G>Tp.Val1755Val
Exon rankExon 39 of 42
synonymous
Prot: NP_065209.2UniProt: P16157-1

Ensembl Transcripts

ANK1 ENST00000289734.13
TSL:1MANE Select
HGVSc / HGVSpc.5265G>Tp.Val1755Val
Exon rankExon 39 of 43
synonymous
Prot: ENSP00000289734.8UniProt: P16157-3
ANK1 ENST00000265709.14
TSL:1
HGVSc / HGVSpc.5388G>Tp.Val1796Val
Exon rankExon 40 of 43
synonymous
Prot: ENSP00000265709.8UniProt: P16157-21
ANK1 ENST00000347528.8
TSL:1
HGVSc / HGVSpc.5265G>Tp.Val1755Val
Exon rankExon 39 of 42
synonymous
Prot: ENSP00000339620.4UniProt: P16157-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:37
GnomAD4 genome
Cov:33
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign9.1
BayesDel_noAF
Benign-0.71
CADD
Benign1.6
DANN
Benign0.64
GPN-Star LLR
N/A-3.3
GPN-Star score
N/A3.3
PhyloP100
Benign1.3
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.